Hannah Valantine - Director at BridgeBio Pharma, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
BBIO on Nasdaq
All Insider Reports
All Insider Reports

Hannah Valantine - trading volume in the past year for BridgeBio Pharma, Inc.

Holdings reported by Hannah Valantine for BridgeBio Pharma, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,465 $506,453 $67.84 27 Feb 2026 Direct
Common Stock 398 $27,083 $68.05 27 Feb 2026 By Spouse
Stock Option (Right to Buy) 0 27 Feb 2026 Direct Common Stock

Transactions reported by Hannah Valantine for BridgeBio Pharma, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.